← Leaderboards
David E Kelley
University Of Pittsburgh At Pittsburgh
$11,733,618
Attributed
$11,733,618
Total exposure
22
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.7M · FY2005–06$5M$3.8M$2.5M$1.3M$0
'05
'06
Funding mix
By agency
NIH$17,922,059 · 23
By mechanism
U01$7,636,544 · 1
P30$6,540,080 · 2
R01$2,705,237 · 2
M01$696,282 · 17
K24$343,916 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Iva Miljkovic$10,053,351
- Xinyan Tracy Cui$15,273,948
- Radosveta P Koldamova$12,908,953
- Takashi Daniel Yoshida Kozai$9,290,586
- Kathryn H. Schmitz$25,381,755
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman SubjectNoninsulin Dependent Diabetes MellitusObesityStriated MusclesInsulin Sensitivity /ResistanceHuman Therapy EvaluationMuscle MetabolismPositron Emission TomographyBody CompositionExerciseMagnetic Resonance ImagingClinical Trial Phase IWeight LossNutrition Related TagClinical TrialsGlucose MetabolismFree Fatty AcidsDiabetes Mellitus TherapyOutcomes ResearchGlucose TransportLipid MetabolismDisease /Disorder Proneness /RiskCarotid Artery
Grant awards (77)
Obesity/Nutrition Research Center$1,047,684
P30 · FY2006 · DK · contact PI
Mitochondrial Impairment in Muscle Insulin Resistance$301,980
R01 · FY2006 · DK · contact PI
Obesity/Nutrition Research Center$1,085,150
P30 · FY2005 · DK
STUDY OF HEALTH OUTCOMES OF WEIGHT-LOSS (SHOW)$1,073,049
U01 · FY2005 · DK
Mitochondrial Impairment in Muscle Insulin Resistance$309,755
R01 · FY2005 · DK
LOOK AHEAD STUDY: ACTION FOR HEALTH IN DIABETES$117,917
M01 · FY2005 · RR
MITOCHONDRIAL IMPAIRMENT IN MUSCLE INSULIN RESISTANCE$66,287
M01 · FY2005 · RR
MULTI-TRACER PET QUANT SKELETAL MUSCLE INSULIN RESIST TYPE 2 DIABETES MELLITUS$27,648
M01 · FY2005 · RR
LOOK AHEAD: ANCILLARY STUDY: MRI DERIVED ORGAN TISSUE MASS WEIGHT LOSS$18,987
M01 · FY2005 · RR
MULTI-TRACER PET QUANTITATION OF INSULIN ACTION IN MUSCLE$7,662
M01 · FY2005 · RR
LOOK AHEAD ANCILLARY STUDY: FAT CELL SIZE, MUSCLE LIPID INFILTRATION$4,997
M01 · FY2005 · RR
LOOK AHEAD ANCILLARY STUDY: MRI DERIVED ORGAN AND TISSUE MASS CHANGES WITH$2,923
M01 · FY2005 · RR
MITOCHONDRIAL IMPAIRMENT IN MUSCLE INSULIN RESISTANCE$1,594
M01 · FY2005 · RR
PET IMAGING OF REGIONAL VARIATION IN INSULIN SENSITIVITY OF FATTY TISSUES HUMANS$999
M01 · FY2005 · RR
Obesity/Nutrition Research Center$1,097,891
P30 · FY2004 · DK
STUDY OF HEALTH OUTCOMES OF WEIGHT-LOSS (SHOW)$1,070,013
U01 · FY2004 · DK
Multi-Tracer PET Quantitation of Insulin Action$374,268
R01 · FY2004 · DK
Mitochondrial Impairment in Muscle Insulin Resistance$310,192
R01 · FY2004 · DK
Look AHEAD Study: Action for Health in Diabetes$306,015
M01 · FY2004 · RR
SKELETAL MUSCLE METABOLISM OF FATTY ACIDS$42,911
K24 · FY2004 · DK
Look AHEAD: Fat Cell Size, Muscle Lipid Infiltration$36,376
M01 · FY2004 · RR
Multi-Tracer PET Quantitation of Insulin in Muscle$30,525
M01 · FY2004 · RR
Look AHEAD: MRI Derived Organ/Tissue Weight Loss$26,201
M01 · FY2004 · RR
PET Quant Skeletal Muscle Insulin Resist NIDDM$11,701
M01 · FY2004 · RR
Look AHEAD Ancillary Study: MRI Derived Organ and Tissue Mass Changes with$9,852
M01 · FY2004 · RR
Mitochondrial Impairment in Muscle Insulin Resistance$7,631
M01 · FY2004 · RR
Contrast Enhanced US Capillary Recruit Muscle$763
M01 · FY2004 · RR
STUDY OF HEALTH OUTCOMES OF WEIGHT-LOSS (SHOW)$1,870,170
U01 · FY2003 · DK
Obesity/Nutrition Research Center$1,107,716
P30 · FY2003 · DK
Multi-Tracer PET Quantitation of Insulin Action$363,258
R01 · FY2003 · DK
SKELETAL MUSCLE METABOLISM OF FATTY ACIDS$72,323
K24 · FY2003 · DK
STUDY OF HEALTH OUTCOMES OF WEIGHT-LOSS (SHOW)$7,450
U01 · FY2003 · DK
Clinical Center for Look AHEAD: Health in Diabetes$1,525,988
U01 · FY2002 · DK
Multi-Tracer PET Quantitation of Insulin Action$482,238
R01 · FY2002 · DK
OBESITY/NUTRITION RESEARCH CENTER$370,000
P30 · FY2002 · DK
CORE--CLINICAL ASSESSMENT FACILITY$103,677
P30 · FY2002 · DK
SKELETAL MUSCLE METABOLISM OF FATTY ACIDS$57,595
K24 · FY2002 · DK
Clinical Center for Look AHEAD: Health in Diabetes$7,475
U01 · FY2002 · DK
GLUCAGON RECEPTOR ANTAGONIST BAY 27 9955 IN NIDDM$0
M01 · FY2002 · RR
EFFECTS OF NIDDM ON GLUCOSE TRANSPORT IN SKELETAL MUSCLE$0
M01 · FY2002 · RR
EFFECTS OF NIDDM ON GLUCOSE TRANSPORT IN SKELETAL MUSCLE$0
M01 · FY2002 · RR
EXAMINATION OF SKELETAL MUSCLE FAT CONTENT BY MRI--EFECTS OF OBESITY AND NIDDM$0
M01 · FY2002 · RR
EXAMINATION OF SKELETAL MUSCLE FAT CONTENT BY MRI--EFECTS OF OBESITY AND NIDDM$0
M01 · FY2002 · RR
LIPID METABOLISM IN PREGNANCY AND WITH PREECLAMPSIA$0
M01 · FY2002 · RR
LIPID METABOLISM IN PREGNANCY AND WITH PREECLAMPSIA$0
M01 · FY2002 · RR
TROGLITAZONE, METFORMIN, &SULFONYLUREA IN INSULIN STIMULATED GLUCOSE$0
M01 · FY2002 · RR
TROGLITAZONE, METFORMIN, &SULFONYLUREA IN INSULIN STIMULATED GLUCOSE$0
M01 · FY2002 · RR
EFFECTS OF OBESITY ON MUSCLE FFA UTILIZATION$0
M01 · FY2002 · RR
EFFECTS OF OBESITY ON MUSCLE FFA UTILIZATION$0
M01 · FY2002 · RR
SDZ DJN608 &GLYBURIDEON IN BASAL &POSTPRANDIAL HEPATIC GLUCOSE$0
M01 · FY2002 · RR
SDZ DJN608 &GLYBURIDEON IN BASAL &POSTPRANDIAL HEPATIC GLUCOSE$0
M01 · FY2002 · RR
GLUCAGON RECEPTOR ANTAGONIST BAY 27 9955 IN NIDDM$0
M01 · FY2002 · RR
Clinical Center for Look AHEAD: Health in Diabetes$1,159,066
U01 · FY2001 · DK
OBESITY/NUTRITION RESEARCH CENTER$740,000
P30 · FY2001 · DK
OBESITY EFFECTS ON MUSCLE FFA UTILIZATION$285,938
R01 · FY2001 · DK
CORE--CLINICAL ASSESSMENT FACILITY$103,677
P30 · FY2001 · DK
SKELETAL MUSCLE METABOLISM OF FATTY ACIDS$86,409
K24 · FY2001 · DK
Clinical Center for Look AHEAD: Health in Diabetes$7,500
U01 · FY2001 · DK
EFFECTS OF NIDDM ON GLUCOSE TRANSPORT IN SKELETAL MUSCLE$0
M01 · FY2001 · RR
SDZ DJN608 &GLYBURIDEON IN BASAL &POSTPRANDIAL HEPATIC GLUCOSE$0
M01 · FY2001 · RR
GLUCAGON RECEPTOR ANTAGONIST BAY 27 9955 IN NIDDM$0
M01 · FY2001 · RR
EFFECTS OF OBESITY ON MUSCLE FFA UTILIZATION$0
M01 · FY2001 · RR
TROGLITAZONE, METFORMIN, &SULFONYLUREA IN INSULIN STIMULATED GLUCOSE$0
M01 · FY2001 · RR
LIPID METABOLISM IN PREGNANCY AND WITH PREECLAMPSIA$0
M01 · FY2001 · RR
EXAMINATION OF SKELETAL MUSCLE FAT CONTENT BY MRI--EFECTS OF OBESITY AND NIDDM$0
M01 · FY2001 · RR
Clinical Center for Look AHEAD: Health in Diabetes$915,833
U01 · FY2000 · DK
OBESITY/NUTRITION RESEARCH CENTER$740,000
P30 · FY2000 · DK
OBESITY EFFECTS ON MUSCLE FFA UTILIZATION$277,608
R01 · FY2000 · DK
CORE--CLINICAL ASSESSMENT FACILITY$144,285
P30 · FY2000 · DK
SKELETAL MUSCLE METABOLISM OF FATTY ACIDS$84,678
K24 · FY2000 · DK
EXAMINATION OF SKELETAL MUSCLE FAT CONTENT BY MRI--EFECTS OF OBESITY AND NIDDM$3,034
M01 · FY2000 · RR
EFFECTS OF NIDDM ON GLUCOSE TRANSPORT IN SKELETAL MUSCLE$3,034
M01 · FY2000 · RR
SDZ DJN608 &GLYBURIDEON IN BASAL &POSTPRANDIAL HEPATIC GLUCOSE$3,034
M01 · FY2000 · RR
EFFECTS OF OBESITY ON MUSCLE FFA UTILIZATION$3,034
M01 · FY2000 · RR
TROGLITAZONE, METFORMIN, &SULFONYLUREA IN INSULIN STIMULATED GLUCOSE$3,034
M01 · FY2000 · RR
LIPID METABOLISM IN PREGNANCY AND WITH PREECLAMPSIA$3,034
M01 · FY2000 · RR
GLUCAGON RECEPTOR ANTAGONIST BAY 27 9955 IN NIDDM$0
M01 · FY2000 · RR